Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth. Click here to learn more ›

Melanocortin Agonist PL9643 Significantly Improves Ocular Signs and Symptoms of Moderate to Severe Dry Eye Disease, Including Tear Film Break Up Time

Scroll to Top